[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345002-105":59,"doc-detail-345002-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","analysis-of-cancer-stem-cell-mechanism-and-immune-profiling-in-breast-cancer-of-unknown-primary","Analysis of cancer stem cell mechanism and immune profiling in breast cancer of unknown primary","","Cancer of unknown primary (CUP) comprises a highly heterogeneous group of cancers marked by limited therapeutic options and poor prognosis. Pathogenesis and immune profiling remain insufficiently defined, motivating identification of actionable targets. Thirteen breast CUP samples and five metastatic breast cancers underwent gene expression analysis, validating a cancer stem cell phenotype driven by TCL1A overexpression. Breast CUPs showed diverse genomic alterations, enhanced immune infiltration, inflammatory signatures, increased PD-L1 trends, and TIL elevation. In triple-negative breast cancer cells, TCL1A overexpression promoted proliferation, invasion, and sphere formation while suppressing apoptosis, activating CSC and EMT markers via enriched AKT signaling. TCL1A-AKT may represent a potential therapeutic axis in an inflamed immune microenvironment.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/analysis-of-cancer-stem-cell-mechanism-and-immune-profiling-in-breast-cancer-of-unknown-primary/345002/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/analysis-of-cancer-stem-cell-mechanism-and-immune-profiling-in-breast-cancer-of-unknown-primary/345002.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main focus of this study on cancer of unknown primary (CUP)?","Question",{"text":113,"@type":114},"The study focused on elucidating the cancer stem cell mechanism and immune profiling in breast CUP, aiming to uncover potential therapeutic targets.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were the breast CUP samples analyzed in the study?",{"text":118,"@type":114},"Thirteen breast CUP samples and five metastatic breast cancers were subjected to gene expression analysis, followed by validation of the TCL1A-driven CSC phenotype using cytological experiments.",{"name":120,"@type":111,"acceptedAnswer":121},"What role did TCL1A play in breast CUP and TNBC cell lines?",{"text":122,"@type":114},"TCL1A was more highly expressed in CUP than in metastases with known primaries, and in triple-negative breast cancer cell lines its overexpression promoted proliferation, invasion, and sphere formation while inhibiting apoptosis and enhancing CSC and EMT marker expression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345002,1790797794,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Clinical and Experimental Medicine (2026) 26:192  \n[https://doi.org/10.1007/s10238-026-02086-7](https://doi.org/10.1007/s10238-026-02086-7)  \nRESEARCH  \nAnalysis of cancer stem cell mechanism and immune profiling in breast cancer of unknown primary  \nMin Ren1,2,3 · Chen Chen1,2,3 · Zijuan Hu1,2,3 · Yu Yang1,2,3 · Ping Wei1,2,3 · Xiaoyan Zhou1,2,3,4  \nReceived: 14 September 2025 / Accepted: 2 February 2026 © The Author(s) 2026  \nAbstract  \nCancer of unknown primary (CUP) encompasses a highly heterogeneous group of cancers with limited therapeutic options and a dismal prognosis. To date, the pathogenesis and immune profiling of CUP have not been fully characterized which could provide more therapeutic targets.Samples of thirteen breast CUPs and five known metastatic breast cancers were subjected to gene expression analysis. The identified cancer stem cell (CSC) phenotype induced by the overexpression of T-cell leukemia/lymphoma-1 A (TCL1A) was validated via cytological experiments.Compared with known metastatic breast cancers, breast CUPs presented various genetic abnormalities mainly involving pluripotency in stem cells and upregulation of immune-related signaling pathways. CUPs also had significantly greater immune cell infiltration and tumor inflammation signature scores, accompanied by a higher trend of PD-L1 expression and tumor-infiltrating lymphocytes. TCL1A, a gene associated with stem cell-like features, was more highly expressed in various types of CUP than in metastases with known primary sites. In triple-negative breast cancer cell lines, overexpression of TCL1A promoted cell proliferation, invasion, and sphere formation and inhibited apoptosis; it also markedly upregulated CSC and epithelialmesenchymal transition marker expression. Analysis of the downstream signaling pathways affected by TCL1A revealed notable enrichment of the AKT pathway.Breast CUP is characterized by complex genomic alterations and an inflamed immune microenvironment. The significant overexpression of TCL1A and the enrichment of CSC signatures suggest that the TCL1A-AKT axis may serve as a potential therapeutic target, highlighting the CSC phenotype as a critical biological mechanism in the tumorigenesis and progression of CUP.  \nKeywords Cancer of unknown primary · Immune profiling · Cancer stem cell · Biological mechanism · T-cell leukemia/lymphoma-1A  \nAbbreviations  \nMin Ren and Chen Chen contributed equally.  \n􀀍 Xiaoyan Zhou [xyzhou100@163.com](xyzhou100@163.com)  \n1 Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China  \n2 Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China  \n3 Institute of Pathology, Fudan University, Shanghai 200032, China  \n4 Fudan University Shanghai Cancer Center, 270 Dong’an Road, Shanghai 200032, China  \nCUP  \nTCL1A  \nCSC  \nEMT  \nFFPE  \nHE  \nPD-L1  \nCPS  \nTILs  \nqRT-PCR  \nBC  \nKEGG  \nGO  \nDEG  \nTIS  \nCancer of unknown primary T-cell leukemia/lymphoma-1A Cancer stem cell  \nEpithelial-mesenchymal transition Formalin-fixed paraffin-embedded Hematoxylin-eosin Programmed cell death ligand 1  \nCombined positive score  \nTumor-infiltrating lymphocytes Quantitative real-time polymerase chain reaction  \nBreast cancer  \nKyoto Encyclopedia of Genes and Genomes Gene Ontology  \nDifferentially expressed gene Tumor Inflammation Signature  \n1 3  \nTMB Tumor mutation burden  \nCIN Chromosomal instability  \nTNBC Triple negative breast cancer  \nIntroduction  \nCancer of unknown primary (CUP) encompasses a highly heterogeneous group of cancers characterized by aggressive biological behaviour without a detectable primary site despite a comprehensive diagnostic strategy [1–3] . Many studies have focused on the diagnosis and treatment of CUP, yielding numerous vital findings [4–8] . However, regardless of whether molecular-guided site-specific treatment or empirical therapy is used, the prognosis of CUP is still poor, except the minority with favorable subgroup [1] . Im","cbCainKsHDgyznKf","https://ap.wps.com/l/cbCainKsHDgyznKf","pdf",3344820,14,"English","# Introduction\n## Clinical background and diagnostic challenge of CUP\n## Proposed mechanisms, including cancer stem cell model\n## Immune microenvironment and immunotherapy relevance in CUP\n## Study rationale and objectives for breast CUP","[{\"question\":\"What was the main focus of this study on cancer of unknown primary (CUP)?\",\"answer\":\"The study focused on elucidating the cancer stem cell mechanism and immune profiling in breast CUP, aiming to uncover potential therapeutic targets.\"},{\"question\":\"How were the breast CUP samples analyzed in the study?\",\"answer\":\"Thirteen breast CUP samples and five metastatic breast cancers were subjected to gene expression analysis, followed by validation of the TCL1A-driven CSC phenotype using cytological experiments.\"},{\"question\":\"What role did TCL1A play in breast CUP and TNBC cell lines?\",\"answer\":\"TCL1A was more highly expressed in CUP than in metastases with known primaries, and in triple-negative breast cancer cell lines its overexpression promoted proliferation, invasion, and sphere formation while inhibiting apoptosis and enhancing CSC and EMT marker expression.\"}]","Analysis of cancer stem cell mechanism and immune profiling in breast cancer of unknown primary | PDF",1790056139,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3175113665e55e2ff4ae6ae61164ee35.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/648f9201690b15812167db6d347b46d3.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e07ac86a2134da266f3c724b801999d.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/349e97b7d60f2ad9b9c52299ca8f1a66.webp",980,1301]